Aurobindo Pharma Ltd
The live share price of Aurobindo Pharma Ltd (AUROPHARMA) as on 03 May 10:13am is ₹1,151.65 from NSE/BSE.
AUROPHARMA NSE
₹1,151.65 ▼-0.41% (-4.7)
As on May 03, 2024 03:43 PM IST
Key Metrics
PE Ratio
24.4
PB Ratio
2.52
Dividend Yield
0.65%
Sector PB
5.96
Sector PE
52.69
Sector Div Yld
0.57%
Dividend Yield
Dividend per share for the most recent financial year divided by the close price
About
Sector
Health Care
Industry
Pharmaceuticals
Market Cap
Midcap, ₹67,588 Cr
Aurobindo Pharma Limited is a pharmaceutical company. The Company is engaged in producing oral and injectable generic formulations and active pharmaceutical ingredients (APIs).
The following charts display the financial performance of the Aurobindo Pharma Ltd (AUROPHARMA) stock, including the year-on-year Income Statement , Balance Sheet , Cash Flow Statement and Shareholding pattern.
Furthermore, under the Peers section, you can find stocks that are similar to Aurobindo Pharma Ltd (AUROPHARMA), and their live stock price and performance at a glance. Click on any peer stock to navigate to that stock’s live price page.
✅ If you’re new to investing in the stock market, and/or are unsure about your investment options, you can explore smallcases.
A smallcase is a readymade stock/ETF portfolio (also known as a stock basket) that is based on an investment idea, theme or strategy. Examples of popular smallcases include All Weather Investing , Equity and Gold , Top 100 Stocks , Green Energy and Value & Momentum.
All smallcases are created and managed by SEBI-registered investment experts.
To invest in smallcases, all you need is a demat/trading account. You retain complete ownership of the smallcase’s constituent stocks or ETFs, as they are directly credited to your broking account. You can choose from over 500+ smallcases across 180+ smallcase managers to start your investment journey.
Sector
Health Care
Industry
Pharmaceuticals
Market Cap
Midcap, ₹67,588 Cr
Financials
Income Statement
| (INR) | Y/Y Change | |
| Revenue | 25,145 Cr | +5.25% |
| Operating Expense | 1,375 Cr | -47.31% |
| Net Income | 1,927 Cr | -27.21% |
| Net Profit Margin | 7.67% | -30.78% |
| Earning Per Share | 32 | -27.21% |
| EBITDA | 3,997 Cr | -12.1% |
Balance sheet
| (INR) | Y/Y Change | |
| Cash & short-term Inv | 6,235 Cr | +36.47% |
| Total Assets | 39,505 Cr | +17.44% |
| Total Liabilities | 12,653 Cr | +39.6% |
| Total Equity | 26,851 Cr | +9.27% |
| Shares Outstanding | 58.59 Cr | -0.01% |
| Price to Book | 1.13 | -30.55% |
| Return on Assets | 5.27% | -33.29% |
| Return on Capital | 10.25 Cr | -26.36% |
Cash Flows
| (INR) | Y/Y Change | |
| Net Income | 1,927 Cr | -27.21% |
| Cash from Operations | 2,386 Cr | -52.42% |
| Cash from Investing | -3,977 Cr | +23.87% |
| Cash from Financing | 1,814 Cr | -161.11% |
| Net Change in Cash | 223 Cr | -119.19% |
| Free Cash Flow | -333 Cr | -114.43% |
Peers
SUNPHARMA
Sun Pharmaceutical Industries Ltd
PE Ratio
40.47
1Y Return
▲56.11%
CIPLA
Cipla Ltd
PE Ratio
30.48
1Y Return
▲54.74%
DRREDDY
Dr Reddy's Laboratories Ltd
PE Ratio
19.76
1Y Return
▲27.01%
ZYDUSLIFE
Zydus Lifesciences Ltd
PE Ratio
32.26
1Y Return
▲84.46%
Latest News
Aurobindo Pharma falls after US FDA issues 3 observations on Andhra arm
4 weeks ago on Moneycontrol
Change since news ▼-INF%
Aurobindo Pharma share price | The share touched a 52-week high of Rs 1,177.00 and a 52-week low of Rs 517.55 on 30 January, 2024 and 05 April, 2023, respectively.
Aurobindo Pharma Unit Gets 3 Observations From USFDA After Inspection
4 weeks ago on Bloomberg Quint
Change since news ▼-INF%
Aurobindo Pharma’s subsidiary, Eugia Steriles, received three observations from the USFDA after an inspection of its manufacturing unit in Andhra Pradesh.
Aurobindo Pharma Commissions Four Plants In Andhra Pradesh Including Pen-G Facility
1 month ago on Bloomberg Quint
Change since news ▼-INF%
The injectable plant has the capacity to produce 285 millions of Vials/Ampoules annually and the Granulated products plant will produce 13,200 tonne annually, Aurobindo said.
Aurobindo Pharma commissions four plants in Andhra Pradesh including Pen-G facility
1 month ago on Moneycontrol
Change since news ▼-INF%
Penicillin-G (Pen-G) facility, located in a SEZ at Kakinada in Andhra Pradesh, has a production capacity of 15,000 tonne per annum and also 1.8 lakh tonne of gulcose, while 6-Amino Penicillanic Acid plant has a capacity to produce 3,600 tonne annually, the drug maker said in a press release.
Aurobindo Pharma Arm Extends Negotiations Deadline With MSD For Contract Manufacturing Operations
1 month ago on Bloomberg Quint
Change since news ▼-INF%
Aurobindo Pharma’s subsidiary, CuraTeQ Biologics, has extended the deadline for negotiations with Merck Sharp & Dohme Singapore for contract manufacturing operations for biologicals until May 2024.
Aurobindo Pharma Bought Electoral Bonds Worth Rs 52 Crore, BJP Biggest Beneficiary
1 month ago on Bloomberg Quint
Change since news ▼-INF%
Aurobindo Pharma purchased electoral bonds worth Rs 52 crore, with over half going to the BJP, according to Election Commission data.
Aurobindo Pharma share up nearly 2% on USFDA approval for nasal spray
1 month ago on Moneycontrol
Change since news ▼-INF%
The share touched a 52-week high of Rs 1,177 on January 30, 2024 and a 52-week low of Rs 466 on March 21, 2023.
Aurobindo Pharma trades 2% down as US FDA spots issues in Telangana unit
2 months ago on Moneycontrol
Change since news ▼-INF%
Aurobindo Pharma subsidiary’s Telangana plant was slapped with 7 observations by the US FDA after its inspection of the unit from February 19-29.
Aurobindo Pharma To Commence Production At Andhra Pen G Facility In Two Years
2 months ago on Bloomberg Quint
Change since news ▼-INF%
The plant will have a production capacity of around 15,000 tonne annually.
Aurobindo Pharma restarts aseptic product distribution; shares trade higher
2 months ago on Moneycontrol
Change since news ▼-INF%
The share touched a 52-week high of Rs 1,177.00 and a 52-week low of Rs 443.15 on 30 January, 2024 and 14 March, 2023, respectively.
FAQs on Aurobindo Pharma Ltd
How to buy Aurobindo Pharma Ltd stocks?
You can easily buy the stocks/shares of Aurobindo Pharma Ltd (AUROPHARMA) through either a broker or a financial institution by opening a Demat & Trading account online via smallcase.
What is the Share Price of Aurobindo Pharma Ltd?
The stock price of Aurobindo Pharma Ltd as on 03 May 2024 is ₹1,151.65
What is the 52-week High and Low of Aurobindo Pharma Ltd?
The 52-week high and low of Aurobindo Pharma Ltd (AUROPHARMA) is ₹1,177.1 and ₹581.25.
What is the PE and PB ratio of Aurobindo Pharma Ltd?
The P/E (price-to-earnings) and P/B (price-to-book) ratios of Aurobindo Pharma Ltd are 24.4 and 2.52 respectively.
What are the peers or stocks similar to Aurobindo Pharma Ltd?
The peers or stocks similar to Aurobindo Pharma Ltd are Sun Pharmaceutical Industries Ltd, Cipla Ltd, Dr Reddy's Laboratories Ltd, Zydus Lifesciences Ltd and many others. smallcase also offers over 200 readymade stock baskets managed by 180+ SEBI-registered investment experts. These stock portfolios are based on a theme, idea or strategy. You can use smallcase to start investing in diversified stock baskets.
Which sector does Aurobindo Pharma Ltd belong to?
Aurobindo Pharma Ltd (AUROPHARMA) belongs to the Pharmaceuticals sector.
What is the Market Cap of Aurobindo Pharma Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Aurobindo Pharma Ltd (AUROPHARMA) is ₹67,588 Cr as of 03 May 2024
Can't decide whether or not to buy Aurobindo Pharma Ltd stocks? ⭐️
Worry no more! smallcase offers readymade stock baskets/portfolios that are based on an theme, idea or strategy. You can choose from more than 500+ stock portfolios managed by 180+ SEBI-registered investment experts.
smallcase Technologies Private Limited
#51, 3rd Floor, Le Parc Richmonde,
Richmond Road, Shanthala Nagar,
Richmond Town, Bangalore - 560025
All smallcases present in the articles are created by SEBI licensed entities. The disclosure of these entities can be found below:
INH200007645
INH100008717
INA000017541
INH100008513
INA100015717
INP000004946
INA000016825
INA000007623
INA200013770
INH000009445
INH000006077
INH000006448
INA000015701
INA000016436
INA000017231
INP000006749
INH000004635
INH300006607
INA300002022
INH000009630
INA200013798
INA300017038
INA000017198
INH200003208
INA300012547
INA000016463
INH000008677
INA000014915
INA100004608
INP000006253
INH000007216
INA100013205
INA300008614
INA200010904
INA000016056
INH000001139
INA000010584
INH100009488
INA100015115
INH200009935
INH000008312
INH100008638
INA100014426
INA000015747
INH000008075
INH000006156
INA300003616
INH000008552
INH100008726
INH000001469
INH000009047
INH100008799
INH100008939
INA100010402
INH200009032
